Oncology Formulations
Dec 28, 2010 at 16:00 | Source: CNBC-TV18
Aug 05, 2010 at 16:08 | Source: CNBC-TV18
Jun 21, 2008 at 16:25
May 30, 2008 at 18:15
Feb 26, 2008 at 14:36
Related News »
In the first quarter, the Company also acquired U.S. oncology market rights to a topical sodium hyaluronate ... vital clinical need for patients who cannot tolerate existing tablet formulations of this drug. DARA plans to begin marketing Soltamox in ...
May 21, 2012 at 14:57 | Source: GlobeNewsWire (press release)
About APP Pharmaceuticals APP Pharmaceuticals is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and ...
May 23, 2012 at 12:17 | Source: Marketwatch
In the first quarter, the Company also acquired U.S. oncology market rights to a topical sodium ... vital clinical need for patients who cannot tolerate existing tablet formulations of this drug. DARA plans to begin marketing Soltamox in the ...
May 26, 2012 at 13:39 | Source: Yahoo Finance
Dr. Hortobagyi chairs the department of Breast Medical Oncology and directs the Breast Cancer Research ... and product-based company developing proprietary vaccine formulations for large, unmet medical needs. The Company's Ii-Key Hybrid ...
May 9, 2012 at 13:24 | Source: Boston Globe
"We look forward to the opportunity to introduce nanomedicine in oncology to the medical market in Russia ... looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates ...
May 22, 2012 at 06:34 | Source: Reuters
differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela ...
May 21, 2012 at 04:12 | Source: Marketwatch
The 1- and 3-month formulations of Pamorelin® LA are available immediately ... us to provide patients and doctors with an innovative product in the areas of oncology and gynaecology," added Josef Troxler, General Manager of the Swiss affiliate ...
May 15, 2012 at 09:56 | Source: TMCnet
She has served as co-chair of the Hoosier Oncology Group Breast Committee since early 2002 ... The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth ...
May 15, 2012 at 13:24 | Source: CNBC
In addition, the New Zealand Intellectual Property Office issued a Notice of Acceptance for New Zealand patent application number 576,242, entitled "Stabilized Prostaglandin E Composition," which claims formulations of Vitaros®, Apricus Bio's ...
May 25, 2012 at 17:44 | Source: msnbc.com
TONIX seeks to use new doses and formulations of cyclobenzaprine in new treatment ... In 2000 Dr. Lederman founded Targent Pharmaceuticals to develop late-stage oncology drugs. In 1998 Dr. Lederman co-founded Vela Pharmaceuticals, which ...
May 23, 2012 at 11:55 | Source: Yahoo Finance